Negative Regulation of Myeloid-derived Suppressor Cells in Cancer
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature myeloid cells with suppressive function on immune response. In this review, we discuss recent studies about mechanisms of expansion and suppressive function of MDSCs during inflammation, infection and autoimmune diseases, as well as pro-angiogenic and pro-metastatic functions of these cells in tumor development. Further, we focus on novel studies of MDSCs and therapeutic approaches to eliminate these cells in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · cited 2×
“Thus, miRNAs could couple with transcription factors in development and differentiation of MDSCs, contributing to cancerassociated inflammation (Chaudhuri et al., 2011; O’Connell et al., 2007).”
BackgroundHuang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435 · cited 2×
“Interestingly, the production of NO was not required for MDSC induction of Tregs, whereas NO produced by iNOS has been shown to be involved in the T cell dysfunction induced byMDSCs (Huang et al., 2006).”
BackgroundRegulation of progenitor cell proliferation and granulocyte function by microRNA-223
Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., Brummelkamp, T. R., Fleming, M. D., & Camargo, F. D. (2008) · Nature · doi:10.1038/nature06607 · Cited by 1,208 · cited 1×
“In addition, two other miRNAs, miR-155 and miR-223, have also been implicated in the development of MDSCs in mouse models (Johnnidis et al., 2008; O’Connell et al., 2008).”
BackgroundCorzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140 · cited 9×
“Furthermore, MDSCs accumulate in response to some tumor vaccine models in mice, promoting tumor progression and negating the effects of the vaccines, and can also play a role in refractoriness to anti-VEGF tumor therapy (Prins et al., 2002; Serafini et al., 2004a; Shojaei et al., 2007).”
BackgroundSelf-citationSuzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0883 · Cited by 1,054
Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918 · cited 3×
“Suppressive functions are mediated through combinations of several major molecular players, including inducible nitric oxide synthetase (iNOS), arginase-1 (Arg1), cyclo-oxygenase 2 (COX-2), prostaglandin E2 (PGE2) and TGF-β (Li et al., 2009) (Bogdan, 2011) (Yang et al., 2008).”
BackgroundSelf-citationTumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849 · cited 1×
“Furthermore, MDSCs accumulate in response to some tumor vaccine models in mice, promoting tumor progression and negating the effects of the vaccines, and can also play a role in refractoriness to anti-VEGF tumor therapy (Prins et al., 2002; Serafini et al., 2004a; Shojaei et al., 2007).”
BackgroundSinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.977 · Cited by 847 · cited 3×
“…these molecules, GM-CSF, PGE2 and VEGFhave been shown tomediateMDSC accumulation (Bunt et al., 2006; Bunt et al., 2007; Gabrilovich et al., 1998; Huang et al., 2007; Kamiyama et al., 2006; Melani et al., 2003; Serafini et al., 2004a; Sinha et al., 2007b; Solheim et al., 2007; Varga et al., 2008).”
BackgroundHoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.020 · Cited by 793 · cited 1×
“In hepatocellular carcinoma (HCC) patients, the monocytic subset of MDSCs was observed to induce expansion of a population of IL-10 dependent regulatory T cells (Tregs) (Hoechst et al., 2008).”
BackgroundO'Connell, R. M., Rao, D. S., Chaudhuri, A. A., Boldin, M. P., Taganov, K. D., Nicoll, J., Paquette, R. L., & Baltimore, D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072108 · Cited by 681 · cited 1×
“In addition, two other miRNAs, miR-155 and miR-223, have also been implicated in the development of MDSCs in mouse models (Johnnidis et al., 2008; O’Connell et al., 2008).”
BackgroundMyeloid derived suppressor cells in human diseases
Greten, T. F., Manns, M. P., & Korangy, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.003 · Cited by 398 · cited 1×
“Similar findings were observed in experimental autoimmune uveoretinitis (EAU), and in inflammatory bowel disease models (Greten et al., 2011; Haile et al., 2010; Kerr et al., 2008).”
ResultNF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies
Zhao, J. L., Rao, D. S., Boldin, M. P., Taganov, K. D., O'Connell, R. M., & Baltimore, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105398108 · Cited by 386 · cited 2×
“This defect seems to result from an excessive proliferative capacity ofMDSCs in the absence of miR-146a caused by increased CSF-1R expression, producing a more robust proliferation ofMDSCs in response toM-CSFwithout a change in the number of myeloid progenitors (Zhao et al., 2011).”
BackgroundMicroRNA-125b Potentiates Macrophage Activation
Chaudhuri, A. A., So, A. Y.-L., Sinha, N., Gibson, W. S. J., Taganov, K. D., O’Connell, R. M., & Baltimore, D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102001 · Cited by 327
Kerr, E. C., Raveney, B. J. E., Copland, D. A., Dick, A. D., & Nicholson, L. B. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.08.006 · Cited by 162 · cited 1×
“Similar findings were observed in experimental autoimmune uveoretinitis (EAU), and in inflammatory bowel disease models (Greten et al., 2011; Haile et al., 2010; Kerr et al., 2008).”
Result
Cited by
The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
Weinberg, F., Ramnath, N., & Nagrath, D. (2019) · Cancers · doi:10.3390/cancers11081191 · Cited by 502
Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment
Chen, X., Song, M., Zhang, B., & Zhang, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1580967 · Cited by 326
“It has been revealed that MDSCs, as one of the major immunosuppressive subsets, play a pivotal role in promoting tumor progression and contribute to suppressive tumor microenvironment by producing ROS [25, 26].”
Background
Metadata
- Authors
- Qu, P., Boelte, K. C., & Lin, P. C.
- Venue
- Immunological Investigations
- Publisher
- Informa UK Limited
- Published
- 2012-08
- Volume
- 41
- Issue
- 6-7
- Pages
- 562-580
- ISSN
- 0882-0139 (ISSN-L)
- 1532-4311
- OpenAlex
- W2011313606
- Cited by
- 39
- References
- 16
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.